Evaxion A/S - Sponsored ADR (EVAX) vs TScan Therapeutics, Inc. (TCRX)
Evaxion A/S - Sponsored ADR and TScan Therapeutics, Inc. are both Biotechnology companies. Evaxion A/S - Sponsored ADR is the larger, with a market value of $27.2M against $23.7M — 1.1× the size. Evaxion A/S - Sponsored ADR has the higher net margin (0.00% vs −1,655.4%) and the higher return on invested capital (−245.8% vs −4,588.2%). Across the 15 metrics below, Evaxion A/S - Sponsored ADR leads on 10 and TScan Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | EVAX | TCRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (1,695.15%) | 0.00% |
| Net margin | 0.00% | (1,655.35%) | 0.00% |
| Free cash flow margin | 0.00% | (1,665.18%) | 0.00% |
| Return on equity | (96.10%) | (95.80%) | (57.72%) |
| Return on assets | (36.20%) | (50.09%) | (49.22%) |
| Return on invested capital | (245.79%) | (4,588.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack